Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? (Q34479624)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? |
scientific article |
Statements
1 reference
Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? (English)
1 reference
Raviglione MC
1 reference
Gupta R
1 reference
Espinal MA
1 reference
1 December 2001
1 reference
1 reference